Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1924 |
|---|---|
| Identifier | NCT04232553 |
| Trial Title | A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Mirikizumab |
Participant Information
| Sponsor | Eli Lilly and Company |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2020-06-22 |
|---|---|
| Primary Completion Date | 2024-11-28 |
| Completion Date | 2027-04 |